Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000934936-09-000012
Filing Date
2009-03-11
Accepted
2009-03-11 14:28:04
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form_10-k.htm 10-K 1705379
2 2004 EQUITY INCENTIVE PLAN, AS AMENDED exhibit_10-32.htm EX-10.32 253080
3 FORM OF RESTRICTED STOCK PURCHASE AGREEMENT exhibit_10-33.htm EX-10.33 100953
4 EXECUTIVE EMPLOYMENT AGREEMENT exhibit_10-34.htm EX-10.34 118536
5 CONSENT OF GRANT THORNTON LLP exhibit_23-1.htm EX-23.1 2439
6 CERTIFICATION OF CEO exhibit_31-1.htm EX-31.1 16804
7 CERTIFICATION OF CFO exhibit_31-2.htm EX-31.2 17137
8 CERTIFICATION OF CEO exhibit_32-1.htm EX-32.1 6502
9 CERTIFICATION OF CFO exhibit_32-2.htm EX-32.2 6820
  Complete submission text file 0000934936-09-000012.txt   2229368
Mailing Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011 4253681050
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

EIN.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31982 | Film No.: 09672124
SIC: 2835 In Vitro & In Vivo Diagnostic Substances